Recurrent Pterygium Clinical Trial
Official title:
Retrospective Study of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery
| Verified date | February 2014 |
| Source | Kyungpook National University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Korea: Institutional Review Board |
| Study type | Observational |
This study is conducted to evaluate its morphologic reproliferating patterns in patients with pterygium treated with the excision and conjunctival autograft.
| Status | Completed |
| Enrollment | 116 |
| Est. completion date | October 2011 |
| Est. primary completion date | May 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 21 Years to 85 Years |
| Eligibility |
Inclusion Criteria: - Recurrent pterygium - Unilateral or bilateral pterygium - Both male and female - Consenting to participate in study Exclusion Criteria: - Fibrovascular proliferation secondary to injury - Severe dry eye syndrome - Pseudopterygium - Signs of malignancy on pterygium - Corneoscleral trauma or corneo-limbal scars |
Observational Model: Case-Only, Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| Korea, Republic of | Hong Kyun Kim | Daegu | Kyungangpookdo |
| Lead Sponsor | Collaborator |
|---|---|
| Kyungpook National University |
Korea, Republic of,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Pterygium recurrence pattern | Morphologic recurrence pattern of pterygium using consecutively recorded photographs. | 12 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
| Completed |
NCT02007174 -
Bevacizumab Injection for Recurrent Pterygium
|
N/A | |
| Completed |
NCT05362253 -
Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial
|
N/A | |
| Active, not recruiting |
NCT02530801 -
Strategies for Management of Recurrent Pterygium
|
Phase 4 | |
| Recruiting |
NCT04463901 -
Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C
|
N/A | |
| Completed |
NCT01744756 -
Subconjunctival Bevacizumab and Recurrent Pterygium
|
Phase 2/Phase 3 | |
| Completed |
NCT01319721 -
Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane
|
N/A |